| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2014) |
REVIEW |
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 10, No 1 (2014) |
CLINICAL CASE |
THE ATYPICAL SITE OF URETERAL METASTASIS IN A PATIENT WITH CASTRATION-REFRACTORY PROSTATE CANCER. A CLINICAL CASE AND A REVIEW OF LITERATURE |
(Rus)
|
| Vol 10, No 2 (2014) |
PROSTATE CANCER |
SURGICAL TREATMENT OF PATIENTS WITH PROSTATE CANCER AT HIGH RISK OF PROGRESSION |
(Rus)
|
| Vol 8, No 1 (2012) |
PROSTATE CANCER |
THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 9, No 3 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER |
(Rus)
|
| Vol 7, No 2 (2011) |
PROSTATE CANCER |
A ROLE OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER |
(Rus)
|
| Vol 8, No 1 (2012) |
CLINICAL CASE |
RESECTION OF THE S-SHAPED CROSSED DYSTOPIC KIDNEY IN A PATIENT WITH RENAL CELL CARCINOMA |
(Rus)
|
| Vol 7, No 4 (2011) |
LECTURE |
INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 7, No 3 (2011) |
PROSTATE CANCER |
RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER |
(Rus)
|
| Vol 5, No 3 (2009) |
PROSTATE CANCER |
HORMONAL THERAPY WITH LEUPRORELIN (LUCRIN-DEPOT®) IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 5, No 4 (2009) |
LECTURE |
INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 8, No 4 (2012) |
PROSTATE CANCER |
COMBINATION THERAPY FOR PROSTATE CANCER: CLINICAL OBSERVATIONS |
(Rus)
|
| Vol 10, No 3 (2014) |
REVIEW |
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer |
(Rus)
|
| Vol 10, No 4 (2014) |
LECTURE |
Molecular diagnosis of prostate cancer: Topical issues |
(Rus)
|
| Vol 10, No 4 (2014) |
PROSTATE CANCER |
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies |
(Rus)
|
| Vol 11, No 2 (2015) |
LECTURE |
Neoadjuvant targeted therapy in patients with renal cell carcinoma |
(Rus)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Use of sunitinib in patients with metastatic kidney cancer in real clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
PROSTATE CANCER |
Methods for the diagnosis and treatment of oligometastases in patients with prostate cancer and progressive disease after radical treatment |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage lymphadenectomy in patients with lymphogenic prostate cancer progression after radical treatment: results of a multicenter study |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Optimization of sequential targeted therapy |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
PROSTATE CANCER |
Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prospects of 2nd line chemotherapy personalization in patients with metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 13, No 3 (2017) |
CLINICAL CASE |
Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Targeted therapy in patients with poor-prognosis renal cell carcinoma |
(Rus)
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Circulating microRNA expression in connection with prostate cancer lymphogenous metastasis |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice |
(Rus)
|
| Vol 15, No 3 (2019) |
REVIEW |
KIM-1 as a potential serological/urinological tumor-associated marker of renal cell carcinoma and chemotherapy nephrotoxicity |
(Rus)
|
| Vol 15, No 3 (2019) |
UROLOGICAL COMPLICATIONS IN CANCER PATIENTS |
Approaches for breast cancer treatment in kidney transplant recipient |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Alpha-therapy using radium-223 chloride in patients with castration-resistant prostate cancer. From clinical researches to routine practice |
(Rus)
|
| Vol 3, No 3 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Hormonal therapy for prostate cancer |
(Rus)
|
| Vol 3, No 3 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Monitoring of PSA changes and assessment of the diagnostic value of PSA growth rates in patients with prostate cancer after radical prostatectomy |
(Rus)
|
| Vol 3, No 4 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The European Association of Urology guidelines for the diagnosis and management of prostate cancer |
(Rus)
|
| Vol 1, No 2 (2005) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Primary multiple prostate and bladder cancer in patients undergone radical cystoprostatectomy |
(Rus)
|
| Vol 3, No 2 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Adjuvant hormonal therapy as radical treatment of locally advanced prostate cancer |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparing the efficacy of laparoscopic and open radical prostatectomy: analysis of treatment outcomes in patients with prostate cancer treated in three federal centers |
(Rus)
|
| Vol 16, No 4 (2020) |
REVIEW |
Diferelin® as an effective chemical castration agent for patients with prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer |
(Rus)
|
| Vol 17, No 4 (2021) |
REVIEWS |
Modern possibilities of application 99mTc-labeled prostate-specific membrane antigen ligands in prostate cancer |
(Rus)
|
| Vol 18, No 1 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Bladder leiomyosarcoma originating from the muscular elements of the bladder mucosa (clinical case) |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma |
(Rus)
|
| Vol 17, No 4 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Nomograms for predicting the risk of biochemical recurrence in patients with prostate cancer after surgery |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Current capabilities in treatment of non-metastatic castration-resistant prostate cancer: effectiveness, safety, and quality of life of patients taking darolutamide |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Nomograms for predicting local recurrence in prostate cancer patients with a positive resection margin |
(Rus)
|
| Vol 18, No 3 (2022) |
PROSTATE CANCER |
Prevalence of mutations in DNA repair genes in Russian patients with metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 19, No 1 (2023) |
TOPICAL PROBLEM |
Efficacy of avelumab in the treatment of oncourological malignances. Results of registration studies and own experience |
(Rus)
|
| Vol 19, No 2 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical aspects of prostate cancer in patients with germinal and somatic mutations in DNA homologous recombination repair genes |
(Rus)
|
| Vol 19, No 4 (2023) |
REVIEWS |
Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness |
(Rus)
|
| Vol 20, No 2 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical and economic impact of modern pharmaceuticals on reducing mortality from hormone-sensitive prostate cancer with high-volume disease |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Androgen deprivation therapy and cardiological risks in patients with prostate cancer. Are all drugs the same? |
(Rus)
(Eng)
|
| Vol 21, No 2 (2025) |
REVIEWS |
Review of the effectiveness of nuclear magnetic resonance spectroscopy for prostate cancer diagnosis |
(Rus)
|
| Vol 20, No 4 (2024) |
TOPICAL PROBLEM |
Modern approaches to treatment of castration-resistant prostate cancer using targeted radionuclide therapy in patients with bone metastases |
(Rus)
|
| Vol 21, No 4 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Cognizance and adherence to outpatient treatment in patients with prostate cancer after local treatment: multicenter study |
(Rus)
|
| Vol 21, No 4 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Avelumab maintenance therapy: effective standard of drug therapy of metastatic urothelial carcinoma |
(Rus)
|
